RZR-alpha in the Control of Proliferative Vascular Disease

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1002592

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Four million Australians have cardiovascular disease accounting for 35% of all deaths. CVD is the most expensive disease burden and a National Health Priority. Smooth muscle cell growth is a cause of CVD. However, the mechanisms controlling SMC hyperplasia are poorly understood. This project will provide key insights on the role of RZR-alpha in the pathogenesis of blood vessel disease, and develop novel gene-targeting approaches for new opportunities to control complications of CVD.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $521,706.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

atherosclerosis | blood vessels | growth factor | smooth muscle cell | transcription factor | vascular biology

Related Links